FDA FY 2014 Budget Request Suggests Confidence In BsUFA Revenue
This article was originally published in The Pink Sheet Daily
Executive Summary
The biosimilar program hasn’t garnered as many applications as expected this year, but FDA is budgeting that next year’s submissions will meet the more optimistic projections.